Julie Tibbets

Julie Tibbets helps life sciences companies bring breakthrough products to market—and stay there. As chair of Goodwin’s Life Sciences Regulatory & Compliance practice and co-chair of the firm’s Rare Disease Initiative, she combines deep FDA experience with a pragmatic understanding of business objectives and a drive for advancing innovation.

From biologics and drugs to medical devices and software-based tools, Julie helps clients anticipate challenges, manage crises, and align regulatory strategy with corporate goals. She’s often the first call when an issue hits the FDA, the press, or the boardroom.

Julie regularly advises on product development, clinical trials, product marketing, GxP compliance and enforcement. She also leads due diligence and compliance reviews in public offerings, M&A, and private equity investments across the life sciences and medtech ecosystems.

JD, University of North Carolina, Chapel Hill 2004 (Member, Law Review); BA, Purdue University 2001 (Highest Honors, Phi Beta Kappa).